Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shock.
Cardiogenic shock
Extracorporeal membrane oxygenation
Mechanical circulatory support
Timing
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
revised:
18
09
2024
received:
27
06
2024
accepted:
05
10
2024
medline:
24
10
2024
pubmed:
24
10
2024
entrez:
24
10
2024
Statut:
aheadofprint
Résumé
The optimal timing for implementing mechanical circulatory support (MCS) in cardiogenic shock (CS) remains indeterminate. This study aims to evaluate patient characteristics and outcome associated with the time interval between CS onset and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) implementation. In this study, patients with CS treated with MCS at 15 tertiary care centres in three countries were enrolled. Patients treated with MCS were stratified into early (<2 h), intermediate (2-12 h) and delayed (≥12-24 h) MCS implantation by using the time interval between CS onset and MCS device implementation. Adjusted logistic and Cox regression models were fitted to assess the association between timing of MCS implementation, patient characteristics and 30-day mortality. A total of 330 patients with CS treated with VA-ECMO and/or microaxial flow pump were included in this study; 20.9% received early, 55.8% intermediate, and 23.3% delayed MCS. Although crude 30-day mortality was slightly lower in patients with early MCS (58.1% vs. 64.7% vs. 64.3%), adjusted analyses showed no significant association between timing of MCS implantation and 30-day all-cause mortality (hazard ratio [HR] for early vs. intermediate MCS: 0.93, 95% confidence interval [CI] 0.59-1.46, p = 0.74; HR for early vs. delayed MCS: 1.29, 95% CI 0.78-2.13, p = 0.33). Moreover, the incidence of complications, related and unrelated to MCS, did not differ significantly among groups. In this exploratory study of patients with CS treated with MCS, the timing of device implantation within 24 h after CS onset was not associated with mortality. This supports a restrictive MCS approach, reserving its application for patients experiencing CS deterioration despite conventional therapy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: A review and incorporation of validation studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association. J Am Coll Cardiol 2022;79:933–946. https://doi.org/10.1016/j.jacc.2022.01.018
Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association. Circulation 2017;136:e232–e268. https://doi.org/10.1161/CIR.0000000000000525
Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, et al. Fifteen‐year trends in incidence of cardiogenic shock hospitalization and in‐hospital mortality in the United States. J Am Heart Assoc 2021;10:e021061. https://doi.org/10.1161/JAHA.121.021061
Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Sørensen A, et al. Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: A Danish cohort study. Eur J Heart Fail 2019;21:1370–1378. https://doi.org/10.1002/ejhf.1566
Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: Results from an international, multicenter cohort study. Circulation 2020;142:2095–2106. https://doi.org/10.1161/CIRCULATIONAHA.120.048792
Schrage B, Beer BN, Savarese G, Dabboura S, Yan I, Sundermeyer J, et al. Eligibility for mechanical circulatory support devices based on current and past randomised cardiogenic shock trials. Eur J Heart Fail 2021;23:1942–1951. https://doi.org/10.1002/ejhf.2274
Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, et al. Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock. Eur J Heart Fail 2023;25:562–572. https://doi.org/10.1002/ejhf.2796
Møller JE, Engstrøm T, Jensen LO, Eiskjær H, Mangner N, Polzin A, et al.; DanGer Shock Investigators. Microaxial flow pump or standard care in infarct‐related cardiogenic shock. N Engl J Med 2024;390:1382–1393. https://doi.org/10.1056/NEJMoa2312572
Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non‐infarction related cardiogenic shock in the United States. Clin Res Cardiol 2017;107:287–303. https://doi.org/10.1007/S00392‐017‐1182‐2
Beer BN, Kellner C, Goßling A, Sundermeyer J, Besch L, Dettling A, et al. Complications in patients with cardiogenic shock on veno‐arterial extracorporeal membrane oxygenation therapy: Distribution and relevance. Results from an international, multicentre cohort study. Eur Heart J Acute Cardiovasc Care 2024;13:203–212. https://doi.org/10.1093/ehjacc/zuad129
Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, et al. Association of use of an intravascular microaxial left ventricular assist device vs intra‐aortic balloon pump with in‐hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2020;323:734–745. https://doi.org/10.1001/jama.2020.0254
Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019;139:1249–1258. https://doi.org/10.1161/CIRCULATIONAHA.118.036614
Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al.; ECLS‐SHOCK Investigators. Extracorporeal life support in infarct‐related cardiogenic shock. N Engl J Med 2023;389:1286–1297. https://doi.org/10.1056/NEJMoa2307227
Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al.; ECMO‐CS Investigators. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO‐CS randomized clinical trial. Circulation 2023;147:454–464. https://doi.org/10.1161/CIRCULATIONAHA.122.062949
Lee HH, Kim HC, Ahn CM, Lee SJ, Hong SJ, Yang JH, et al. Association between timing of extracorporeal membrane oxygenation and clinical outcomes in refractory cardiogenic shock. JACC Cardiovasc Interv 2021;14:1109–1119. https://doi.org/10.1016/j.jcin.2021.03.048
Jentzer JC, Drakos SG, Selzman CH, Owyang C, Teran F, Tonna JE. Timing of initiation of extracorporeal membrane oxygenation support and outcomes among patients with cardiogenic shock. J Am Heart Assoc 2024;13:32288. https://doi.org/10.1161/JAHA.123.032288
Choi KH, Yang JH, Hong D, Park TK, Lee JM, Song YB, et al. Optimal timing of venoarterial‐extracorporeal membrane oxygenation in acute myocardial infarction patients suffering from refractory cardiogenic shock. Circ J 2020;84:1502–1510. https://doi.org/10.1253/circj.CJ‐20‐0259
Iannaccone M, Franchin L, Hanson ID, Boccuzzi G, Basir MB, Truesdell AG, et al. Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta‐analysis. Int J Cardiol 2022;362:47–54. https://doi.org/10.1016/J.IJCARD.2022.05.011
Schrage B, Sundermeyer J, Blankenberg S, Colson P, Eckner D, Eden M, et al. Timing of active left ventricular unloading in patients on venoarterial extracorporeal membrane oxygenation therapy. JACC Heart Fail 2023;11:321–330. https://doi.org/10.1016/j.jchf.2022.11.005
Henry TD, Tomey MI, Tamis‐Holland JE, Thiele H, Rao SV, Menon V, et al. Invasive management of acute myocardial infarction complicated by cardiogenic shock: A scientific statement from the American Heart Association. Circulation 2021;143:e815–e829. https://doi.org/10.1161/CIR.0000000000000959
Sundermeyer J, Dabboura S, Weimann J, Beer BN, Becher PM, Seiffert M, et al. Short‐term lactate kinetics in patients with cardiogenic shock. JACC Heart Fail 2023;11:481–483. https://doi.org/10.1016/j.jchf.2023.01.013
Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, et al. Clinical presentation, shock severity and mortality in patients with de novo versus acute‐on‐chronic heart failure‐related cardiogenic shock. Eur J Heart Fail 2024;2023:432–444. https://doi.org/10.1002/ejhf.3082
Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, et al. Standardized team‐based care for cardiogenic shock. J Am Coll Cardiol 2019;73:1659–1669. https://doi.org/10.1016/j.jacc.2018.12.084
Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, et al. Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock. Clin Res Cardiol 2024;113:570–580. https://doi.org/10.1007/s00392‐023‐02332‐y
Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, et al. Early extracorporeal membrane oxygenator‐assisted primary percutaneous coronary intervention improved 30‐day clinical outcomes in patients with ST‐segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010;38:1810–1817. https://doi.org/10.1097/CCM.0b013e3181e8acf7
Huang CC, Hsu JC, Wu YW, Ke SR, Huang JH, Chiu KM, et al. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST‐segment elevation myocardial infarction and refractory cardiogenic shock. Int J Cardiol 2018;269:45–50. https://doi.org/10.1016/j.ijcard.2018.07.023
Del Rio‐Pertuz G, Benjanuwattra J, Juarez M, Mekraksakit P, Argueta‐Sosa E, Ansari MM. Efficacy of mechanical circulatory support used before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from ST‐elevation myocardial infarction: A systematic review and meta‐analysis. Cardiovasc Revasc Med 2022;42:74–83. https://doi.org/10.1016/j.carrev.2022.05.002
Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct‐related cardiogenic shock: An individual patient data meta‐analysis of randomised trials. Lancet 2023;402:1338–1346. https://doi.org/10.1016/S0140‐6736(23)01607‐0
Uriel N, Sayer G, Annamalai S, Kapur NK, Burkhoff D. Mechanical unloading in heart failure. J Am Coll Cardiol 2018;72:569–580. https://doi.org/10.1016/j.jacc.2018.05.038